TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.065
-0.055 (-4.91%)
At close: Jan 28, 2026, 4:00 PM EST
1.130
+0.065 (6.10%)
After-hours: Jan 28, 2026, 4:05 PM EST
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $60.44 million as of January 28, 2026. Its market cap has decreased by -61.39% in one year.
Market Cap
60.44M
Enterprise Value
-27.54M
1-Year Change
-61.39%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $60.44M, a decrease of -83.17%. That is a compound annual growth rate of -32.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 63.56M | 12.00% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 65.38M |
| PMV Pharmaceuticals | 64.39M |
| NRx Pharmaceuticals | 63.95M |
| InflaRx | 62.37M |
| Metagenomi Therapeutics | 62.14M |
| Alterity Therapeutics | 60.66M |
| MiNK Therapeutics | 60.55M |
| Acrivon Therapeutics | 59.01M |